Diabetes In Control While 24.5% patients on metformin required an add-on oral medication , 37.1% of patients on sulfonylurea, 39.6% of patients on thiazolidinedione , and 36.2% patients on DPP-4 inhibitor required an add-on oral medication . Moreover, 5.1% of patients on ...
DigitalJournal.com Actos, a widely prescribed diabetes medication since 1999, is a type of thiazolidinedione (TZD) that has been connected to a slew of serious side effects such as bladder cancer, cardiovascular problems, liver issues and bone fractures. It was reported ... and more »
MarketWatch It will be evaluated in conjunction with current treatments such as metformin, thiazolidinedione and/or long-acting insulin analog on glycemic control in patients with Type 2 diabetes. HbA1c, also known as glycated hemoglobin, ... Upon receipt of FDA ... and more »
Food Consumer Trulicity has been studied as a stand-alone therapy and in combination with other type 2 diabetes therapies, including metformin, sulfonylurea, thiazolidinedione , and prandial insulin. Trulicity should not be used to treat people with type 1 diabetes ... and more »
Diabetes Health (press release) Trulicity can be used alone or in conjunction with existing type 2 treatments including metformin, sulfonylureas, thiazolidinedione and prandial insulin to help control blood sugar levels, according to Mary Parks, M.D., deputy director of the Office of ...
Medscape Scientists have developed a computer model that can predict how drugs will affect the liver, and they have used it to demonstrate that they could have identified the relatively rare risk for hepatotoxicity with the type 2 diabetes drug troglitazone ...
Medical Xpress In 2013, the Cleveland Clinic published research with similar outcomes using another type of diabetes drug , thiazolidinedione . Several study trials are examining the use of Metformin and healthy lifestyle changes as a complement to chemotherapy for ... and more »
Monthly Prescribing Reference A review in the journal Clinical Diabetes evaluates the safety and efficacy of saxagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, as an add-on therapy to metformin, sulfonylurea (SU), a thiazolidinedione (TZD), or insulin (with or without ...
